CN Stock MarketDetailed Quotes

688621 Beijing Sun-Novo Pharmaceutical Research

Watchlist
  • 42.48
  • +0.10+0.24%
Market Closed Dec 12 15:00 CST
4.76BMarket Cap21.49P/E (TTM)

About Beijing Sun-Novo Pharmaceutical Research Company

The company was founded in 2009 and is one of the first CRO companies (ContractResearchOrganization) in China to provide drug research and development services to the outside world. As an external resource that pharmaceutical manufacturers can borrow, the company can quickly organize a highly specialized and experienced research team in a short period of time after receiving a request from a customer, thereby helping pharmaceutical manufacturers speed up the progress of drug research and development, reduce drug development costs, and achieve high-quality research. The company's main business covers comprehensive R&D services in innovative drug development, generic drug development and consistency evaluation. The company's products mainly include drug discovery, pharmacological efficacy, pharmaceutical research, clinical research and biological analysis. The company's corporate honors include: Beijing Enterprise Technology Center, Beijing Enterprise Science and Technology Research and Development Agency 2020, Chengdu High-tech Zone Seed Stage Young Eagle Enterprise 2019, China's Top 20 Pharmaceutical Research and Development 2019, etc.

Company Profile

Short Name-A阳光诺和
Company NameBeijing Sun-Novo Pharmaceutical Research Co.,Ltd.
Listing DateJun 21, 2021
Issue Price26.89
Shares Offered20.00M share(s)
FoundedMar 9, 2009
Chairmanqian li
Legal Representativeyujing liu
General Manageryujing liu
Secretaryliping wei
Employees1394
ProvinceBei Jing Shi
Phone010-60748199
Office Address1st Floor, Building 7, No. 79 Shuangying West Road, Science Park, Changping District, Beijing
Zip Code102200
Registered Address1st Floor, Building 7, No. 79 Shuangying West Road, Science Park, Changping District, Beijing
Fax010-60748199
Emailir@sun-novo.com
Business License91110107685771683F
BusinessThe company's main business is to provide specialized R&D outsourcing services for pharmaceutical companies, covering comprehensive R&D services in generic drug development, consistency evaluation, and innovative drug development. The services mainly include pharmaceutical research, clinical trials and bioanalysis.

Company Executives

  • Name
  • Position
  • Salary
  • qian li
  • Chairman, Directors
  • 1.50M
  • yujing liu
  • Directors, General Manager
  • 2.25M
  • zhijiao zhang
  • Directors, Chief Financial Officer
  • --
  • wenran li
  • Directors
  • --
  • qiao chen
  • Directors
  • --
  • zhuangkun he
  • Independent Directors
  • 120.00K
  • xian shi
  • Independent Directors
  • 90.00K
  • huiting zhu
  • Independent Directors, Strategy and ESG Committee Member, Audit and Risk Committee Member, Chairman of the Nomination Committee
  • --
  • zibing huang
  • Securities Affairs Representative
  • --
  • dandan wang
  • Chairman of the Supervisory Board, Auditors
  • 743.12K
  • zhen zhou
  • Auditors
  • 302.16K
  • huan luo
  • Deputy General Manager, Core Technical Personnel
  • 1.32M
  • yan shao
  • Deputy General Manager
  • --
  • guangtao hao
  • Deputy General Manager, Core Technical Personnel
  • 1.11M
  • guangpeng meng
  • Core Technical Personnel
  • 364.65K
  • yuanbo li
  • Core Technical Personnel
  • 938.21K
  • yuanfeng tong
  • Core Technical Personnel
  • 1.00M
  • aihua nie
  • Core Technical Personnel
  • --
  • yu yuan
  • Core Technical Personnel
  • 836.85K
  • jinfeng zhang
  • Employee Supervisors
  • 3.80M